Evidence map›Paper›PMID 26869457›Full record

ArticleBiomolecules & therapeutics2016

Mitochondria-Targeted Vitamin E Protects Skin from UVB-Irradiation.

Won-Serk Kim, Ikyon Kim, Wang-Kyun Kim, Ju-Yeon Choi, Doo Yeong Kim, Sung-Guk Moon, Hyung-Keun Min, Min-Kyu Song, Jong-Hyuk Sung

Open access · greenAbstract read
In one paragraph

Article in Biomolecules & therapeutics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Won-Serk KimDepartment of Dermatology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul 03181, Republic of Korea.
Ikyon KimCollege of Pharmacy, Yonsei University, Incheon 21983, Republic of Korea.
Wang-Kyun KimCollege of Pharmacy, Yonsei University, Incheon 21983, Republic of Korea.
Ju-Yeon ChoiDepartment of Dermatology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul 03181, Republic of Korea.
Doo Yeong KimCollege of Pharmacy, Yonsei University, Incheon 21983, Republic of Korea.
Sung-Guk MoonCollege of Pharmacy, Yonsei University, Incheon 21983, Republic of Korea.
Hyung-Keun MinCleanup Dermatologic Clinic, Seoul 07301, Republic of Korea.
Min-Kyu SongCleanup Dermatologic Clinic, Seoul 07301, Republic of Korea.
Jong-Hyuk SungCollege of Pharmacy, Yonsei University, Incheon 21983, Republic of Korea.
Yonsei University · KRSungkyunkwan University · KRThe Ocean Cleanup · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondria-targeted vitamin E (MVE) is designed to accumulate within mitochondria and is applied to decrease mitochondrial oxidative damage. However, the protective effects of MVE in skin cells have not been identified. We investigated the protective effect of MVE against UVB in dermal fibroblasts and immortalized human keratinocyte cell line (HaCaT). In addition, we studied the wound-healing effect of MVE in animal models. We found that MVE increased the proliferation and survival of fibroblasts at low concentration (i.e., nM ranges). In addition, MVE increased collagen production and downregulated matrix metalloproteinase1. MVE also increased the proliferation and survival of HaCaT cells. UVB increased reactive oxygen species (ROS) production in fibroblasts and HaCaT cells, while MVE decreased ROS production at low concentration. In an animal experiment, MVE accelerated wound healing from laser-induced skin damage. These results collectively suggest that low dose MVE protects skin from UVB irradiation. Therefore, MVE can be developed as a cosmetic raw material.

Indexed as

CollagenFibroblastHaCaTMitochondria-Targeted vitamin EUVB protection

Identifiers

PMID26869457
PMCPMC4859794
OpenAlexW2343990213

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.